Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    March 2018
  1. CHENG W, Liu W, Li B, Li D, et al
    Relations of Anticoagulant Therapy with Cognitive Impairment among Patients with Atrial Fibrillation: A Meta-Analysis and Systematic Review.
    J Cardiovasc Pharmacol. 2018 Mar 2. doi: 10.1097/FJC.0000000000000575.
    PubMed     Text format     Abstract available


    October 2017
  2. CARSTENSEN H, Kjaer L, Haugaard MM, Flethoj M, et al
    Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses.
    J Cardiovasc Pharmacol. 2017 Oct 25. doi: 10.1097/FJC.0000000000000541.
    PubMed     Text format     Abstract available


  3. CHOI J, Kim J, Shim JH, Kim M, et al
    Risks Versus Benefits of Anticoagulation for Atrial Fibrillation in Cirrhotic Patients.
    J Cardiovasc Pharmacol. 2017;70:255-262.
    PubMed     Text format     Abstract available


    July 2017
  4. DE VRIES LJ, Geczy T, Szili-Torok T
    Sleep medications containing melatonin can potentially induce ventricular arrhythmias in structurally normal hearts: a two-patient report.
    J Cardiovasc Pharmacol. 2017 Jul 13. doi: 10.1097/FJC.0000000000000515.
    PubMed     Text format     Abstract available


  5. BANOVCIN P JR, Skornova I, Samos M, Schnierer M, et al
    Platelet aggregation in direct oral factor Xa inhibitors-treated patients with atrial fibrillation: a pilot study.
    J Cardiovasc Pharmacol. 2017 Jul 13. doi: 10.1097/FJC.0000000000000516.
    PubMed     Text format     Abstract available


    June 2017
  6. BOSSU A, Varkevisser R, Beekman HDM, Houtman MJC, et al
    Short-term Variability of Repolarization Is Superior to Other Repolarization Parameters in the Evaluation of Diverse Antiarrhythmic Interventions in the Chronic Atrioventricular Block Dog.
    J Cardiovasc Pharmacol. 2017;69:398-407.
    PubMed     Text format     Abstract available


    May 2017
  7. VECSERNYES M, Szokol M, Bombicz M, Priksz D, et al
    Alpha-Melanocyte-stimulating Hormone Induces Vasodilation and Exerts Cardioprotection Through the Heme-Oxygenase Pathway in Rat Hearts.
    J Cardiovasc Pharmacol. 2017;69:286-297.
    PubMed     Text format     Abstract available


    March 2017
  8. LIU Y, Scherlag BJ, Fan Y, Xia W, et al
    Acetylcholine-Atropine Interactions: Paradoxical Effects on Atrial Fibrillation Inducibility.
    J Cardiovasc Pharmacol. 2017 Mar 21. doi: 10.1097/FJC.0000000000000484.
    PubMed     Text format     Abstract available


    February 2017
  9. YAMAJI H, Murakami T, Hina K, Higashiya S, et al
    Safety and Efficacy of Underdosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    J Cardiovasc Pharmacol. 2017;69:118-126.
    PubMed     Text format     Abstract available


    December 2016
  10. SILVA AF, Bonatti R, Batatinha J, Nearing BD, et al
    The Selective Late Sodium Current Inhibitor, Eleclazine, Unlike Amiodarone, Does Not Alter Defibrillation Threshold or Dominant Frequency of Ventricular Fibrillation.
    J Cardiovasc Pharmacol. 2016 Dec 28. doi: 10.1097/FJC.0000000000000455.
    PubMed     Text format     Abstract available


    November 2016
  11. YAMAJI H, Murakami T, Hina K, Higashiya S, et al
    Safety and Efficacy of Under-dosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  12. YAMAJI H, Murakami T, Hina K, Higashiya S, et al
    Safety and Efficacy of Under-dosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    J Cardiovasc Pharmacol. 2016 Nov 22. doi: 10.1097/FJC.0000000000000448.
    PubMed     Text format     Abstract available


  13. BEATCH GN, Bhirangi K, Juul-Moller S, Rustige J, et al
    Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation in the Asia-Pacific region: a phase 3 randomized controlled trial.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  14. GARCIA-PEDRAZA JA, Garcia M, Martin ML, Eleno N, et al
    Chronic sarpogrelate treatment reveals 5-HT7 receptor in the serotonergic inhibition of the rat vagal bradycardia.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  15. SAIRAKU A, Nakano Y, Suenari K, Tokuyama T, et al
    Dexmedetomidine depresses sinoatrial and atrioventricular nodal function without any change in atrial fibrillation inducibility.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  16. WEI X, Zhu A, Zhang Y, Yao S, et al
    Pre- and delayed treatments with ranolazine ameliorate ventricular arrhythmias and Nav1.5 downregulation in ischemic/reperfused rat hearts.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  17. AMINO M, Inokuchi S, Yoshioka K, Nakagawa Y, et al
    Does antiarrhythmic drug during cardio-pulmonary resuscitation improve the one-month survival: The SOS-KANTO 2012 study.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  18. ZAMAN JA, Baykaner T, Narayan SM
    New Mechanism-based Approaches to Ablating Persistent AF: Will Drug Therapy Soon Be Obsolete?
    J Cardiovasc Pharmacol. 2016;67:1-8.
    PubMed     Text format     Abstract available


    December 2015
  19. ZHANG L, Gao S
    Systematic Review and Meta-analysis of Atrial Fibrillation Prophylaxis following Lung Surgery.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  20. HOEKER GS, Hanafy MA, Oster RA, Bers DM, et al
    Reduced Arrhythmia Inducibility with Calcium/Calmodulin-Dependent Protein Kinase II Inhibition in Heart Failure Rabbits.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  21. LU Y, Sun J, Zhou X, Zhang L, et al
    The effect of low-level vagus nerve stimulation on cardiac remodeling in a rapid atrial pacing-induced canine model of atrial fibrillation.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    June 2015
  22. YU HD, Xia S, Zha CQ, Deng SB, et al
    Spironolactone Regulates HCN Protein Expression Through Micro-RNA-1 in Rats With Myocardial Infarction.
    J Cardiovasc Pharmacol. 2015;65:587-92.
    PubMed     Text format     Abstract available


    February 2015
  23. HUANG J, Lin YC, Hileman S, Martin KH, et al
    PP2 prevents isoproterenol stimulation of cardiac pacemaker activity.
    J Cardiovasc Pharmacol. 2015;65:193-202.
    PubMed     Text format     Abstract available


    January 2015
  24. GHOLAMZADEH A, Amini S, Mohammadpour AH, Vahabzadeh M, et al
    Erythropoietin reduces post-PCI arrhythmias in patients with ST-elevation myocardial infarction.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: